By InvitationNot Applicable

Art Education and Creativity in Midwifery Students

Turkey (Türkiye)110 participantsStarted 2025-10-01

Plain-language summary

This randomized controlled trial aims to evaluate the effects of art education on imagination, individual creativity, and state mindfulness levels in midwifery students. The study will be conducted among third-year midwifery students at the Faculty of Health Sciences, Selçuk University, Türkiye. A total of 110 students will be randomly assigned to either an intervention group or a control group. Students in the intervention group will receive at least 10 hours of structured art education (basic cross-stitch training) over four weeks, while the control group will receive no additional intervention. Data will be collected before and after the intervention using the Two-Dimensional Imagination Scale, the Individual Creativity Scale, and the State Mindfulness Scale. The primary objective is to compare changes in imagination, creativity, and mindfulness scores between the intervention and control groups. It is hypothesized that students who receive art education will demonstrate significantly higher levels of imagination, individual creativity, and state mindfulness compared to those who do not receive the intervention. The findings are expected to contribute to the development of holistic, student-centered educational strategies in midwifery education.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Currently enrolled as a third-year midwifery student at Selçuk University, Faculty of Health Sciences. * Willing to voluntarily participate in the study. * For the intervention group: has attended at least 10 hours of art courses or workshops in the past year. * Able to provide written informed consent. Exclusion Criteria: * Diagnosed with a severe psychiatric disorder or currently receiving active psychiatric treatment. * Incomplete participation forms or missing baseline data. * Withdrawal of consent at any stage of the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Imagination Level (Two-Dimensional Imagination Scale Score)

Timeframe: Baseline and Week 4

Trial details

NCT IDNCT07466771

SponsorSelcuk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-01

View on ClinicalTrials.gov More Creativity and Mindfulness trials